Salmedix Alternatives & Competitors
12 companies similar to Salmedix — Pioneering advanced treatments for blood cancers, delivering innovative Phase II...
Companies similar to Salmedix
Geron Corporation
Changing lives by changing the course of blood cancer.
LymphoSign
Pioneering pharmaceuticals in the fight against blood cancers since 2000
Adastra Pharmaceuticals
Adastra is committed to transforming cancer care.
Syntara
Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases linked to fi...
Rival Readout
Competing with Salmedix? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Pacylex Pharmaceuticals, Inc.
A new target in cancer care - triggering selective lethality with a new class of drugs.
Inflammx Therapeutics, Inc.
Modulation of Inflammasome mediated Autoinflammation - in Ophthalmology, Nephropathy and...
HiberCell
Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis
Biodexa Pharmaceuticals PLC
Advancing Medicines for a Brighter Future
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Harpoon Therapeutics
SPEARHEADING IMMUNOTHERAPIES
Gossamer Bio
Vision * Connection * Innovation
About Salmedix
Founded in 2000 by David Kabakoff, Salmedix is a pioneer in oncology drug development, focusing on treatments for hematologic malignancies. The company's primary product, SDX-105, has been made available in Germany to address various blood cancers, and is currently undergoing Phase II clinical trials in the U.S. and Ca...
Oncology, Blood Cancers, Phase II Clinical Trials, Hematologic Malignancies, Drug Development, SDX-105, Healthcare Professionals, Germany, U.S., Canada, SDX-101, SDX-102, Clinical-Stage Product Candidates, David Kabakoff, San Diego
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Salmedix: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Salmedix on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.